Estradiol (OestroGel)
Is It Right for You?
A complete guide to Estradiol (OestroGel) — what it treats, how it works, dosages, side effects, and when a clinician may prescribe it following an online consultation.
What Is Estradiol (OestroGel)?
OestroGel is a transdermal hormone replacement therapy (HRT) preparation containing 0.06% estradiol — a bioidentical form of the naturally occurring oestrogen — delivered as a clear, colourless gel applied to the skin once daily. Each pump actuation delivers 0.75 mg of estradiol; the standard starting dose is two pump actuations (1.5 mg) per day.
Like all transdermal oestrogen preparations, OestroGel bypasses hepatic first-pass metabolism, resulting in stable physiological plasma estradiol concentrations and a more favourable thrombotic risk profile compared to oral oestrogen tablets. The gel format offers flexible dose titration in 0.75 mg increments and ease of application, making it a popular and well-tolerated HRT option.
OestroGel is a prescription-only medication in the UK. A licensed clinician must assess your menopausal symptoms, medical history, and contraindications before it can be prescribed.
What Conditions Is OestroGel Used For?
OestroGel is indicated for:
relief of vasomotor symptoms (hot flushes, night sweats), sleep disturbance, and mood changes caused by oestrogen deficiency
improvement in vaginal dryness, discomfort during intercourse, and urinary frequency or urgency
attenuation of postmenopausal bone loss in women at elevated fracture risk when other treatments are inappropriate
OestroGel provides effective relief of oestrogen-deficiency symptoms but does not arrest the natural course of the menopause. Treatment is reviewed regularly to reassess the balance of benefits and risks.
How Does OestroGel Work?
Estradiol, the active ingredient of OestroGel, is the most potent and biologically active of the naturally occurring oestrogens. It acts by binding to oestrogen receptors (ERα and ERβ), which function as ligand-activated transcription factors, modulating gene expression in oestrogen-responsive tissues including the hypothalamus, uterus, vagina, bone, cardiovascular system, and skin.
Vasomotor symptom relief — the thermoregulatory centre in the hypothalamus is sensitive to oestrogen levels. Declining oestrogen at the menopause leads to dysregulation of temperature control, causing hot flushes and sweating. Restoring systemic estradiol to physiological levels re-establishes hypothalamic thermoregulatory stability.
Urogenital restoration — oestrogen maintains the thickness, elasticity, and lubrication of the vaginal and urethral epithelium. Systemic replacement reverses atrophic changes caused by oestrogen deficiency.
Skeletal protection — oestrogen suppresses osteoclast activity by downregulating the RANK-L/RANK signalling pathway, reducing bone resorption and preserving bone mineral density.
Applied to the skin, estradiol is absorbed through the epidermis into the dermal capillaries, achieving stable steady-state plasma concentrations without the hepatic metabolic effects associated with oral administration.
Dosages & Administration
The correct dose depends on the type and severity of infection, age, weight, and kidney function. Always follow your clinician's instructions. The table below is for general reference only.
Administration Tips
Always follow your clinician's instructions. Apply to clean, dry, intact skin on the arms (inner surface), shoulders, or thighs. Allow the gel to dry for two minutes before covering with clothing. Wash hands thoroughly after application to avoid transferring estradiol to other individuals, particularly children or male partners. Women with an intact uterus must use a progestogen alongside OestroGel to protect the endometrium. Your clinician will prescribe an appropriate progestogen.
Side Effects of OestroGel
Common Side Effects
- Local skin reactions at the application site — redness, irritation, or mild rash
- Breast tenderness or enlargement
- Headache or migraine
- Nausea
- Abdominal bloating or discomfort
- Mood changes or irritability
- Breakthrough bleeding or spotting (during the first three months of treatment)
- Venous thromboembolism (VTE) — deep vein thrombosis or pulmonary embolism; unilateral leg swelling, pain, breathlessness, chest pain
- Stroke — sudden severe headache, facial droop, arm weakness, speech disturbance
- Breast cancer — new breast lump, skin dimpling, nipple discharge
- Endometrial cancer — in women using oestrogen without progestogen protection; abnormal or heavy bleeding requires urgent assessment
- Gallbladder disease — right-sided upper abdominal pain, jaundice
OestroGel must be combined with adequate progestogen therapy in any woman who has not had a hysterectomy. Unopposed oestrogen use substantially increases the risk of endometrial hyperplasia and malignancy.
Drug Interactions
Always disclose all prescription drugs, over-the-counter medicines, vitamins, and supplements to your clinician or pharmacist before starting Estradiol (OestroGel)
accelerate estradiol metabolism, reducing plasma levels and clinical efficacy. Alternative or additional HRT management may be required.
oestrogens increase thyroid-binding globulin; women on levothyroxine may require dose adjustment after starting HRT.
oestrogens may alter anticoagulant requirements; monitor INR.
oestrogens may affect glucose tolerance; blood glucose monitoring is advisable when initiating HRT in women with diabetes.
Important Warnings
OestroGel must be combined with adequate progestogen therapy in any woman who has not had a hysterectomy. Unopposed oestrogen use substantially increases the risk of endometrial hyperplasia and malignancy.
Participation in NHS breast screening should continue during HRT use. Women should perform regular self-examination and report any new breast changes promptly.
OestroGel must not be applied near or transferred to children or male partners, as inadvertent oestrogen exposure can cause premature sexual development in children and gynaecomastia in men.
OestroGel must not be initiated until the cause of any undiagnosed abnormal vaginal bleeding has been excluded by clinical assessment.
Speak to a Clinician About Treatment
Getting advice no longer means sitting in a waiting room. Through The GP Service, you can consult with a licensed clinician in minutes — from home, on your lunch break, or wherever works for you. If treatment is clinically appropriate, your clinician can issue a prescription during the consultation. A consultation does not guarantee a prescription.
The treatment you need, when you need it.
OestroGel FAQs
Transdermal oestrogen avoids hepatic first-pass metabolism, resulting in a lower risk of VTE and stroke compared to oral oestrogen. It is considered the preferred route for women with risk factors for thrombosis.
Improvement in vasomotor symptoms is typically noticeable within two to four weeks. Maximum benefit usually develops over one to three months of consistent use.
Dose changes should be made under clinical review. Your clinician will assess your symptom response at one to three months and adjust the number of pump actuations accordingly.
Oestrogen used alone stimulates the uterine lining (endometrium), increasing the risk of endometrial cancer. Progestogen counteracts this effect. If you have had a hysterectomy, a progestogen is not required.
Yes — OestroGel can be used during the perimenopause to manage symptoms, though treatment regimens may differ from those used in established menopause. Your clinician will advise on the appropriate approach.